News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Conference News TCT 2024 DCB Outdo Noncompliant Balloons in Simple Bifurcation Side Branches: DCB-BIF Caitlin E. Cox October 28, 2024
News Conference News TCT 2023 Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80 Michael O'Riordan November 01, 2023
News Conference News TCT 2023 Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out Michael O'Riordan October 25, 2023
News Conference News TCT 2022 SCAAR Registry Delves Into Left Main Revascularization Outcomes Michael O'Riordan September 19, 2022
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Conference News TCT 2021 Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM Michael O'Riordan November 04, 2021
News Conference News TCT 2021 FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD Michael O'Riordan November 04, 2021
News Conference News TCT 2021 No Harm From Thrombolytics in SCAD Patients With STEMI Michael O'Riordan October 13, 2021
News Conference News TCT 2020 Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT Todd Neale October 21, 2020
News Daily News TCT 2019 BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On L.A. McKeown October 02, 2019
News Conference News TCT 2019 Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE Michael O'Riordan September 30, 2019
News Conference News TCT 2019 Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT Caitlin E. Cox September 26, 2019
News Conference News TCT 2019 IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease Michael O'Riordan September 26, 2019
News Conference News TCT 2018 Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials Michael O'Riordan September 25, 2018
News Conference News TCT 2018 More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses Michael O'Riordan September 24, 2018
News Conference News TCT 2018 ReCre8: Physician-Led Study Shows Noninferiority of Polymer-Free Stent Compared With Permanent-Polymer ZES at 1 Year Yael L. Maxwell September 22, 2018
News Conference News TCT 2018 EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis Michael O'Riordan September 21, 2018
News Conference News TCT 2016 LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years Yael L. Maxwell October 30, 2016
News Conference News TCT 2015 LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients Yael L. Maxwell October 14, 2015